학술논문
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Document Type
Article
Author
Moehler, M.; Maderer, A.; Schütz, M.; Berie, L.; Sauvigny, C.; Galle, P.R.; Woerns, M.; Schimanski, C.; Kanzler, S.; Denzer, U.; Lohse, A.; Kolligs, F.T.; Duerr, E.M.; Ebert, M.P.; Distelrath, A.; Geissler, M.; Trojan, J.; Lubomierski, N.; Lammert, F.; Zimmermann, S.; Dollinger, M.M.; Lindig, U.; Wachtlin, D.; Kaiser, A.-K.; Schadmand-Fischer, S.
Source
In: European Journal of Cancer . (European Journal of Cancer, December 2014, 50(18):3125-3135)
Subject
Language
English
ISSN
18790852
09598049
09598049